- MSX-127
-
- $41.00 / 5mg
-
2026-01-26
- CAS:6616-56-4
- Min. Order:
- Purity: 99.93%
- Supply Ability: 10g
- NSC23026
-
- $1.00 / 1g
-
2019-12-24
- CAS:6616-56-4
- Min. Order: 1g
- Purity: 99%
- Supply Ability: 20kg
|
| | NSC23026 Basic information |
| Product Name: | NSC23026 | | Synonyms: | NSC23026;MSX-127;MSX-127(NSC23026);MSX-127; MSX 127; MSX127; NSC 23026; NSC23026; NSC-23026; NSC 47883; NSC47883; NSC-47883;NSC 47883;NSC47883;NSC-47883;2,5-Bis(morpholinomethyl)benzene-1,4-diol | | CAS: | 6616-56-4 | | MF: | C16H24N2O4 | | MW: | 308.37 | | EINECS: | | | Product Categories: | | | Mol File: | 6616-56-4.mol |  |
| | NSC23026 Chemical Properties |
| Melting point | 201-203 °C | | Boiling point | 486.7±40.0 °C(Predicted) | | density | 1.278±0.06 g/cm3(Predicted) | | storage temp. | under inert gas (nitrogen or Argon) at 2-8°C | | solubility | DMSO : 41.67 mg/mL (135.13 mM; Need ultrasonic) | | pka | 10.29±0.48(Predicted) | | form | Solid | | color | White to off-white |
| | NSC23026 Usage And Synthesis |
| Uses | MSX-127 is a CXCR4 antagonist. MSX-127 inhibits cancer metastasis[1]. | | IC 50 | CXCR4 | | References | [1] Zhan W, et al. Discovery of small molecule CXCR4 antagonists. J Med Chem. 2007 Nov 15;50(23):5655-64. DOI:10.1021/jm070679i |
| | NSC23026 Preparation Products And Raw materials |
|